Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes

DOI10.1111/biom.13377zbMath1520.62136MaRDI QIDQ6055509

Daniel O. Scharfstein, Alex Luedtke, Unnamed Author, Unnamed Author, Unnamed Author, Michael G. Rosenblum

Publication date: 30 October 2023

Published in: Biometrics (Search for Journal in Brave)

zbMATH Keywords

survival analysis; covariate adjustment; COVID-19; randomized trial; ordinal outcomes

Mathematics Subject Classification ID

62P10: Applications of statistics to biology and medical sciences; meta analysis

Related Items

Bayesian computational methods for state-space models with application to SIR model, Design aspects of COVID‐19 treatment trials: Improving probability and time of favorable events, Discussion on “Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment for binary, ordinal, and time‐to‐event outcomes”, Estimation of the odds ratio in a proportional odds model with censored time-lagged outcome in a randomized clinical trial

Cites Work

• Unnamed Item
• Semiparametric estimation of treatment effect with time-lagged response in the presence of informative censoring
• Robust methods to improve efficiency and reduce bias in estimating survival curves in randomized clinical trials
• Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards
• Lasso adjustments of treatment effect estimates in randomized experiments
• Causal Inference on the Difference of the Restricted Mean Lifetime Between Two Groups
• Nonparametric Estimation from Incomplete Observations
• Improving Efficiency of Inferences in Randomized Clinical Trials Using Auxiliary Covariates
• Asymptotic Statistics
• Group-Sequential Analysis Incorporating Covariate Information
• Semiparametric Efficiency and Its Implication on the Design and Analysis of Group-Sequential Studies
• Adjusting for Nonignorable Drop-Out Using Semiparametric Nonresponse Models
• High-dimensional regression adjustments in randomized experiments
• Landmark Estimation of Survival and Treatment Effect in a Randomized Clinical Trial
• Efficiency Study of Estimators for a Treatment Effect in a Pretest–Posttest Trial
• Robust Alternatives to ANCOVA for Estimating the Treatment Effect via a Randomized Comparative Study
• Enhanced precision in the analysis of randomized trials with ordinal outcomes